Agilent’s MP-AES Among R&D Magazine’s R&D 100
News Jun 25, 2012
Agilent Technologies Inc. has announced that its 4100 Microwave Plasma-Atomic Emission Spectrometer (MP-AES) is among the winners of the prestigious R&D 100 Award.
“The 4100 MP-AES fundamentally changed the way scientists conduct elemental analysis,” said Philip Binns, Agilent vice president for spectroscopy products.
Binns continued, “Its launch in 2011 created an entirely new product category while offering the lowest cost of ownership for elemental analysis, along with improved laboratory safety. We are honored that this breakthrough elemental analysis instrument was recognized with an R&D 100 Award.”
The R&D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing and biotechnology.
Winners are selected by an independent judging panel and the editors of R&D Magazine.
The 4100 MP-AES uses a nitrogen-based plasma generator that runs on air, and thus does not require flammable or expensive gases.
With no external cylinder connections required and no need for ongoing gas supplies, the 4100 MP-AES is ideal for any elemental analysis laboratory, especially remote sites and mobile laboratories.
By eliminating the need to plumb multiple gases into the laboratory or manually transport and handle gas cylinders, the 4100 MP-AES also improves lab safety.
Compact Chemical Sensor Can Detect Substances from Over 100 Feet AwayNews
A chemical sensor prototype developed at the University of Michigan will be able to detect "single-fingerprint quantities" of substances from a distance of more than 100 feet away, and its developers are working to shrink it to the size of a shoe box. The development offers great potential for medical and law enforcement purposes.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE